Becton Dickinson And Company Stock News

Becton, Dickinson and Company (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Becton, Dickinson and Company''s (BDX) board approved the spinoff of its diabetes care business, which will be known as Embecta, and declared a pro rata distribution of Embecta shares of

Becton, Dickinson and Co (NYSE: BDX ) has acquired Cytognos , a unit of Vitro SA , a Spanish diagnostics company that develops, produces, and sells fully integrated reagents, hardware, and software platforms. Deal terms were not disclosed . Cytognos specializes in flow cytometry solutions for blood cancer diagnosis, minimal residual disease (MRD) detection, and immune … Full story available on Benzinga.com

Becton, Dickinson and Co (NYSE: BDX) has acquired Cytognos, a unit of Vitro SA, a Spanish diagnostics company that develops, produces, and sells fully integrated reagents, hardware, and software pl

Continued strength in BD's (BDX) Life Sciences and Interventional segments is expected to have driven up Q1 sales.

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Dividend King club is an exclusive one. It takes good management to grow a dividend for 50 or more years, and these two healthcare stocks offer that.

A slew of strategic acquisitions are driving the top line for BD (BDX).

Becton, Dickinson And Co. (BDX) shares closed today at 0.7% below its 52 week high of $264.50, giving the company a market cap of $74B. The stock is currently up 4.4% year-to-date, up 1.7% over the past 12 months, and up 61.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.2%. Trading Activity Trading volume this week was 37.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -165.5% The company's stock price performance over the past 12 months lags the peer average by -83.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -36.9% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Becton, Dickinson And Co. (BDX) shares closed today at 0.7% below its 52 week high of $264.50, giving the company a market cap of $74B. The stock is currently up 4.4% year-to-date, up 3.3% over the past 12 months, and up 61.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 27.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -165.5% The company's stock price performance over the past 12 months lags the peer average by -69.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -36.9% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Becton, Dickinson And Co. (BDX) shares closed today at 0.3% below its 52 week high of $264.50, giving the company a market cap of $74B. The stock is currently up 4.1% year-to-date, up 0.9% over the past 12 months, and up 60.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 26.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -178.2% The company's stock price performance over the past 12 months lags the peer average by -92.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -37.8% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Beckton, Dickinson and Company is a Profitable Dividend Aristocrat that generates tons of cash.

The 35 Dividend Kings finished 2021 on a bright note adding 8.79% in December. The 8 best dividend kings based on forecasted growth and valuation trailed the average dividend king return by 161 bps in

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic buyouts.